Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"

Valuation: Biogen Inc.

Market Cap 29.02B 25.36B 23.46B 21.89B 41.1B 2,743B 41.4B 279B 108B 1,348B 109B 107B 4,684B P/E 2026 *
31.7x
P/E 2027 * 16.5x
Enterprise Value 34.39B 30.05B 27.8B 25.95B 48.71B 3,250B 49.07B 330B 129B 1,598B 129B 126B 5,552B EV / Sales 2026 *
3.42x
EV / Sales 2027 * 3.12x
Free-Float
85.96%
Yield 2026 *
-
Yield 2027 * -
1 day+0.90%
1 week-0.13%
Current month+1.22%
1 month+2.39%
3 months+8.03%
6 months+13.56%
Current year+12.73%
1 week 193.2
Extreme 193.195
201.75
1 month 184.9
Extreme 184.9
203.45
Current year 160.36
Extreme 160.3645
205.97
1 year 121.05
Extreme 121.05
205.97
3 years 110.04
Extreme 110.035
293.52
5 years 110.04
Extreme 110.035
376.01
10 years 110.04
Extreme 110.035
468.55
Manager TitleAgeSince
Chief Executive Officer 66 14/11/2022
Director of Finance/CFO 60 01/03/2025
Chief Tech/Sci/R&D Officer - 01/01/2021
Director TitleAgeSince
Director/Board Member 69 23/03/2010
Director/Board Member 77 01/01/2010
Director/Board Member 72 19/06/2019
Date Insider Type Main position Quantity % Market Cap.
06-09Free

Director

1,505 0.0010%
06-09Free

Director

1,505 0.0010%
06-09Free

Chairman

2,005 0.0014%
Change 5-day change 1-year change 3-year change Capi.($)
+0.90%-0.13%+59.02%-32.51% 29.02B
0.00%-0.99%+18.94%-21.92% 62.05B
-0.84%-4.48%+50.61%+196.38% 54.52B
-5.75%+29.50%+29.50%+29.50% 41.55B
-2.96%+4.99%-53.01%-60.20% 39.06B
-6.91%+15.85%+135.26%-49.88% 25.38B
+4.14%+0.39%+52.22%+65.37% 19.62B
-1.05%-1.44%-3.02%+139.59% 16.89B
+1.04%+2.25%+60.69%+111.01% 15.89B
+4.49%+1.57%+63.77%+327.94% 12.98B
Average -0.70%+1.71%+41.40%+70.53% 31.7B
Weighted average by Cap. -1.31%+0.79%+34.71%+49.45%

Financials

2026 *2027 *
Net sales 10.05B 8.78B 8.12B 7.58B 14.24B 950B 14.34B 96.55B 37.57B 467B 37.74B 36.92B 1,623B 10.38B 9.07B 8.39B 7.83B 14.7B 981B 14.81B 99.71B 38.79B 482B 38.98B 38.13B 1,676B
Net income 1.18B 1.03B 951M 888M 1.67B 111B 1.68B 11.31B 4.4B 54.69B 4.42B 4.32B 190B 1.97B 1.72B 1.59B 1.49B 2.79B 186B 2.81B 18.91B 7.36B 91.47B 7.39B 7.23B 318B
Net Debt 5.37B 4.69B 4.34B 4.05B 7.61B 508B 7.66B 51.6B 20.08B 250B 20.17B 19.73B 867B 3.35B 2.93B 2.71B 2.53B 4.74B 317B 4.78B 32.17B 12.52B 156B 12.58B 12.3B 541B
Logo Biogen Inc.
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows: - sales of medicines (72%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.; - royalties (7.4%) ; - other (20.6%): primarily revenues from partnership agreements.
Employees
7,500
Date Price Change Volume
22/06/26 198.39 $ +0.92% 424,028
18/06/26 196.58 $ -1.05% 1,729,826
17/06/26 198.67 $ +1.56% 1,009,032
16/06/26 195.61 $ -1.53% 1,110,656
15/06/26 198.64 $ -0.70% 883,963
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
36
Last Close Price
196.58USD
Average target price
220.25USD
Spread / Average Target
+12.04%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BIIB Stock
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!